InsiderClue

Insider trading

Period: 120 months Stock: CHRS Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
When Periodin use
Who Rolein use
The trade Type of trade Minimum amount Plan Share of their own holding
Ownership What the chief executive holds
When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

1 month 12 months 120 months
44 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

Anyone CEO CFO Other officers Directors 10% owners
44 decisions over 120 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

Any44 Buys0 Sells44 Cluster buys
44 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

Any $100K or more $1M or more $10M or more $100M or more $500M or more
44 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
Any Discretionary Scheduled (10b5-1) Not stated Not on a plan
44 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
44 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

44 decisions over 120 months
Stock
Insider
Type ?
Value ↓
Of own stake ↓
Why it stands out
CHRS Coherus Oncology, Inc.
9 Mar 2021
Vexler Vladimir Chief Scientific Officer
Sold, plan not stated
$1.86M 114,240 at 16.25
68.2%
Sold half or more
CHRS Coherus Oncology, Inc.
5 Mar 2021
Anicetti Vincent R Chief Operating Officer
Sold, plan not stated 2×
$412.06K 26,649 at 15.46
33.3%
CHRS Coherus Oncology, Inc.
17 Feb 2021
Anicetti Vincent R Chief Operating Officer
Sold, plan not stated
$43.42K 2,488 at 17.45
4.0%
CHRS Coherus Oncology, Inc.
19 Jan 2021
Anicetti Vincent R Chief Operating Officer
Sold, plan not stated
$44.85K 2,500 at 17.94
4.0%
CHRS Coherus Oncology, Inc.
17 Dec 2020
Anicetti Vincent R Chief Operating Officer
Sold, plan not stated
$43.78K 2,500 at 17.51
7.1%
CHRS Coherus Oncology, Inc.
10 Dec 2020
Vexler Vladimir Chief Scientific Officer
Sold, plan not stated
$318.07K 17,626 at 18.05
32.5%
CHRS Coherus Oncology, Inc.
9 Dec 2020
Vexler Vladimir Chief Scientific Officer
Sold, plan not stated
$903.08K 49,512 at 18.24
57.4%
Sold half or more
CHRS Coherus Oncology, Inc.
7 Dec 2020
Anicetti Vincent R Chief Operating Officer
Sold, plan not stated
$161.90K 8,791 at 18.42
21.3%
CHRS Coherus Oncology, Inc.
4 Dec 2020
Anicetti Vincent R Chief Operating Officer
Sold, plan not stated
$923.69K 49,000 at 18.85
60.1%
Sold half or more
CHRS Coherus Oncology, Inc.
3 Dec 2020
Anicetti Vincent R Chief Operating Officer
Sold, plan not stated
$929.08K 49,756 at 18.67
60.4%
Sold half or more
CHRS Coherus Oncology, Inc.
18 Nov 2020
Anicetti Vincent R Chief Operating Officer
Sold, plan not stated
$77.09K 4,283 at 18.00
11.6%
CHRS Coherus Oncology, Inc.
17 Nov 2020
Anicetti Vincent R Chief Operating Officer
Sold, plan not stated 3×
$326.42K 18,487 at 17.66
36.2%
CHRS Coherus Oncology, Inc.
19 Oct 2020
Anicetti Vincent R Chief Operating Officer
Sold, plan not stated
$57.56K 3,217 at 17.89
6.2%
CHRS Coherus Oncology, Inc.
17 Sep 2020
Anicetti Vincent R Chief Operating Officer
Sold, plan not stated
$94.22K 5,000 at 18.84
9.3%
CHRS Coherus Oncology, Inc.
17 Aug 2020
Anicetti Vincent R Chief Operating Officer
Sold, plan not stated
$96.85K 5,000 at 19.37
9.3%
CHRS Coherus Oncology, Inc.
17 Jul 2020
Anicetti Vincent R Chief Operating Officer
Sold, plan not stated
$273.69K 15,000 at 18.25
23.6%
CHRS Coherus Oncology, Inc.
17 Jun 2020
Anicetti Vincent R Chief Operating Officer
Sold, plan not stated
$43.05K 2,500 at 17.22
4.9%
CHRS Coherus Oncology, Inc.
18 May 2020
Anicetti Vincent R Chief Operating Officer
Sold, plan not stated 2×
$53.11K 3,093 at 17.17
6.0%
CHRS Coherus Oncology, Inc.
20 Apr 2020
Anicetti Vincent R Chief Operating Officer
Sold, plan not stated
$87.55K 5,150 at 17.00
9.7%
CHRS Coherus Oncology, Inc.
17 Apr 2020
Anicetti Vincent R Chief Operating Officer
Sold, plan not stated
$77.85K 5,000 at 15.57
8.6%
CHRS Coherus Oncology, Inc.
18 Feb 2020
Anicetti Vincent R Chief Operating Officer
Sold, plan not stated 3×
$216.39K 10,000 at 21.64
15.9%
CHRS Coherus Oncology, Inc.
17 Jan 2020
Anicetti Vincent R Chief Operating Officer
Sold, plan not stated 3×
$195.93K 10,000 at 19.59
14.7%
CHRS Coherus Oncology, Inc.
16 Dec 2019
Anicetti Vincent R Chief Operating Officer
Sold, plan not stated
$46.73K 2,500 at 18.69
11.5%
CHRS Coherus Oncology, Inc.
14 Nov 2019
Anicetti Vincent R Chief Operating Officer
Sold, plan not stated
$48.15K 2,500 at 19.26
11.5%
CHRS Coherus Oncology, Inc.
14 Oct 2019
Anicetti Vincent R Chief Operating Officer
Sold, plan not stated
$46.00K 2,500 at 18.40
11.5%
CHRS Coherus Oncology, Inc.
16 Sep 2019
Anicetti Vincent R Chief Operating Officer
Sold, plan not stated
$50.08K 2,500 at 20.03
11.5%
CHRS Coherus Oncology, Inc.
14 Aug 2019
Anicetti Vincent R Chief Operating Officer
Sold, plan not stated
$47.50K 2,500 at 19.00
11.5%
CHRS Coherus Oncology, Inc.
15 Jul 2019
Anicetti Vincent R Chief Operating Officer
Sold, plan not stated
$48.00K 2,500 at 19.20
11.5%
CHRS Coherus Oncology, Inc.
10 Sep 2018
FINCK BARBARA K Chief Medical Officer
Sold, plan not stated
$32.70K 1,760 at 18.58
4.5%
CHRS Coherus Oncology, Inc.
13 Aug 2018
FINCK BARBARA K Chief Medical Officer
Sold, plan not stated
$33.48K 1,760 at 19.02
4.5%
CHRS Coherus Oncology, Inc.
10 Jul 2018
FINCK BARBARA K Chief Medical Officer
Sold, plan not stated
$18.90K 1,260 at 15.00
3.3%
CHRS Coherus Oncology, Inc.
9 Jul 2018
FINCK BARBARA K Chief Medical Officer
Sold, plan not stated
$7.52K 500 at 15.03
1.3%
CHRS Coherus Oncology, Inc.
18 Jun 2018
FINCK BARBARA K Chief Medical Officer
Sold, plan not stated
$26.40K 1,760 at 15.00
4.5%
CHRS Coherus Oncology, Inc.
16 May 2018
Lanfear Dennis M See Remarks · indirect
Sold, plan not stated
$341.26K 20,984 at 16.26
1.6%
CHRS Coherus Oncology, Inc.
8 Aug 2017
Herman Alan C. Chief Scientific Officer
Sold, plan not stated
$263.30K 17,535 at 15.02
26.1%
CHRS Coherus Oncology, Inc.
5 Jul 2017
Herman Alan C. Chief Scientific Officer
Sold, plan not stated
$9.00K 600 at 15.00
0.9%
CHRS Coherus Oncology, Inc.
1 Jun 2017
Herman Alan C. Chief Scientific Officer
Sold, plan not stated 2×
$230.29K 11,333 at 20.32
14.3%
CHRS Coherus Oncology, Inc.
1 May 2017
Herman Alan C. Chief Scientific Officer
Sold, plan not stated
$226.63K 11,333 at 20.00
12.5%
CHRS Coherus Oncology, Inc.
3 Apr 2017
Herman Alan C. Chief Scientific Officer
Sold, plan not stated
$234.99K 11,333 at 20.73
11.1%
CHRS Coherus Oncology, Inc.
1 Mar 2017
Herman Alan C. Chief Scientific Officer
Sold, plan not stated
$274.17K 11,333 at 24.19
10.0%
CHRS Coherus Oncology, Inc.
1 Feb 2017
Herman Alan C. Chief Scientific Officer
Sold, plan not stated
$310.15K 11,333 at 27.37
9.1%
CHRS Coherus Oncology, Inc.
3 Jan 2017
Herman Alan C. Chief Scientific Officer
Sold, plan not stated 2×
$316.72K 11,333 at 27.95
8.3%
CHRS Coherus Oncology, Inc.
1 Dec 2016
Herman Alan C. Chief Scientific Officer
Sold, plan not stated 2×
$310.52K 11,333 at 27.40
7.7%
CHRS Coherus Oncology, Inc.
1 Nov 2016
Herman Alan C. Chief Scientific Officer
Sold, plan not stated
$312.04K 11,333 at 27.53
7.2%
Showing 1–44 of 44.